Recent studies have demonstrated that CCND1 activation can induce EMT in tumor cells, such as ovarian cancer [82], breast cancer [83], esophageal cancer [84] and epidermoid carcinoma cells [85]. This evidence concerns the gene CCND1 and ovarian carcinoma.